Case Report
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Apr 26, 2023; 11(12): 2817-2824
Published online Apr 26, 2023. doi: 10.12998/wjcc.v11.i12.2817
Recovery from Bell’s palsy after treatment using uncultured umbilical cord-derived mesenchymal stem cells: A case report
Hyunjun Ahn, Won-Ju Jung, Sang Yeon Lee, Kye-Ho Lee
Hyunjun Ahn, Sang Yeon Lee, Kye-Ho Lee, Stem Cell Treatment and Research Institute, bio Beauty and Health Company, Seoul 04420, South Korea
Won-Ju Jung, Stem Cell Treatment, 97.7 Beauty and Health Clinic, Seoul 04420, South Korea
Author contributions: Ahn H, Jung WJ, Lee SY and Lee KH designed the report; Ahn H and Jung WJ collected the patient’s clinical data; Ahn H and Jung WJ analyzed the data; Ahn H and Lee SY wrote the manuscript; Lee KH provided professional advice and revised the manuscript; all authors issued final approval for the version to be submitted.
Informed consent statement: The patient involved in this study gave her written informed consent authorizing disclosure of her protected health information.
Conflict-of-interest statement: All authors declare that they have no conflicts of interest in relation to this case report.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kye-Ho Lee, PhD, Stem Cell Treatment and Research Institute, bio Beauty and Health Company, 72, UN Village-gil, Yongsan-gu, Seoul 04420, South Korea. khlee@stc365.com
Received: December 21, 2022
Peer-review started: December 21, 2022
First decision: January 30, 2023
Revised: March 13, 2023
Accepted: March 29, 2023
Article in press: March 29, 2023
Published online: April 26, 2023
Processing time: 125 Days and 17 Hours
Core Tip

Core Tip: The effectiveness of the current treatment methods for Bell’s palsy is debated. Therefore, alternative treatments are needed. In this study, we treated a patient with Bell’s palsy classified as moderately severe dysfunction using uncultured umbilical cord-derived mesenchymal stem cells. After follow-up for 32 mo, the paralysis was cured, and there was no recurrence. This method could be a new treatment option to replace existing treatments for Bell’s palsy.